Distinct distribution and prognostic significance of molecular subtypes of breast cancer in Chinese women a population based cohort study
is stromectol available in canada Other therapeutic agents in development which target the action of VEGF at alternate points in the signal transduction cascade intiated by this growth factor include sunitinib which is marketed under the trade name Sutent by Sugen Pfizer and inhibits the kinase activity of the VEGF receptor
